• Testing SAR442970 compared to placebo in adults with moderate to severe Crohn’s disease

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia France Germany Poland Spain
  • Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer’s Disease over 72 weeks

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +2
  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Czechia Denmark France Germany Greece +3
  • Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson’s Disease During OFF-State

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Evaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Czechia Denmark Finland France Germany +7
  • Study of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment

    Recruiting

    4 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark France Germany +5
  • Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +12
  • Study of fosmanogepix compared to standard antifungal drugs for treating invasive mold infections in adults

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Greece Italy +2
  • Early Treatment with Argipressin (Arginine Vasopressin) in Adult Intensive Care Patients with Norepinephrine-Resistant Vasoplegic Shock

    Recruiting

    3 1 1
    Investigated diseases:
    France
  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    3 1 1
    Investigated drugs:
    Germany Poland

powered by